Cargando…

Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling

Atherosclerosis is the most common cause of heart disease and stroke. The use of animal models has advanced our understanding of the molecular signaling that contributes to atherosclerosis. Further understanding of this degenerative process in humans will require human tissue. Plaque removed during...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis-Knowlton, Jessica, Turner, Jacqueline E., Turner, Anna, Damian-Loring, Sydney, Hagler, Nicholas, Henderson, Terry, Emery, Ivette F., Bond, Kyle, Duarte, Christine W., Vary, Calvin P. H., Eldrup-Jorgensen, Jens, Liaw, Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309523/
https://www.ncbi.nlm.nih.gov/pubmed/29795127
http://dx.doi.org/10.1038/s41374-018-0072-1
_version_ 1783383372235538432
author Davis-Knowlton, Jessica
Turner, Jacqueline E.
Turner, Anna
Damian-Loring, Sydney
Hagler, Nicholas
Henderson, Terry
Emery, Ivette F.
Bond, Kyle
Duarte, Christine W.
Vary, Calvin P. H.
Eldrup-Jorgensen, Jens
Liaw, Lucy
author_facet Davis-Knowlton, Jessica
Turner, Jacqueline E.
Turner, Anna
Damian-Loring, Sydney
Hagler, Nicholas
Henderson, Terry
Emery, Ivette F.
Bond, Kyle
Duarte, Christine W.
Vary, Calvin P. H.
Eldrup-Jorgensen, Jens
Liaw, Lucy
author_sort Davis-Knowlton, Jessica
collection PubMed
description Atherosclerosis is the most common cause of heart disease and stroke. The use of animal models has advanced our understanding of the molecular signaling that contributes to atherosclerosis. Further understanding of this degenerative process in humans will require human tissue. Plaque removed during endarterectomy procedures to relieve arterial obstructions is usually discarded, but can be an important source of diseased cells. Resected tissue from carotid and femoral endarterectomy procedures were compared to carotid arteries from donors with no known cardiovascular disease. Vascular smooth muscle cells (SMC) contribute to plaque formation and may determine susceptibility to rupture. Notch signaling is implicated in the progression of atherosclerosis, and plays a receptor-specific regulatory role in SMC. We defined protein localization of Notch2 and Notch3 within medial and plaque SMC using immunostaining, and compared Notch2 and Notch3 levels in total plaques to whole normal arteries using immunoblot. We successfully derived SMC populations from multiple endarterectomy specimens for molecular analysis. To better define the protein signature of diseased SMC, we utilized sequential window acquisition of all theoretical spectra (SWATH) proteomic analysis to compare normal carotid artery SMC to endarterectomy-derived SMC. Similarities in protein profile and differentiation markers validated the SMC identity of our explants. We identified a subset of differentially expressed proteins that are candidates as functional markers of diseased SMC. To understand how Notch signaling may affect diseased SMC, we performed Jagged1 stimulation of primary cultures. In populations that displayed significant growth, Jagged1 signaling through Notch2 suppressed proliferation; cultures with low growth potential were non-responsive to Jagged1. In addition, Jagged1 did not promote contractile smooth muscle actin nor have a significant effect on the mature differentiated phenotype. Thus, SMC derived from atherosclerotic lesions show distinct proteomic profiles, and have altered Notch signaling in response to Jagged1 as a differentiation stimulus, compared to normal SMC.
format Online
Article
Text
id pubmed-6309523
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-63095232019-02-28 Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling Davis-Knowlton, Jessica Turner, Jacqueline E. Turner, Anna Damian-Loring, Sydney Hagler, Nicholas Henderson, Terry Emery, Ivette F. Bond, Kyle Duarte, Christine W. Vary, Calvin P. H. Eldrup-Jorgensen, Jens Liaw, Lucy Lab Invest Article Atherosclerosis is the most common cause of heart disease and stroke. The use of animal models has advanced our understanding of the molecular signaling that contributes to atherosclerosis. Further understanding of this degenerative process in humans will require human tissue. Plaque removed during endarterectomy procedures to relieve arterial obstructions is usually discarded, but can be an important source of diseased cells. Resected tissue from carotid and femoral endarterectomy procedures were compared to carotid arteries from donors with no known cardiovascular disease. Vascular smooth muscle cells (SMC) contribute to plaque formation and may determine susceptibility to rupture. Notch signaling is implicated in the progression of atherosclerosis, and plays a receptor-specific regulatory role in SMC. We defined protein localization of Notch2 and Notch3 within medial and plaque SMC using immunostaining, and compared Notch2 and Notch3 levels in total plaques to whole normal arteries using immunoblot. We successfully derived SMC populations from multiple endarterectomy specimens for molecular analysis. To better define the protein signature of diseased SMC, we utilized sequential window acquisition of all theoretical spectra (SWATH) proteomic analysis to compare normal carotid artery SMC to endarterectomy-derived SMC. Similarities in protein profile and differentiation markers validated the SMC identity of our explants. We identified a subset of differentially expressed proteins that are candidates as functional markers of diseased SMC. To understand how Notch signaling may affect diseased SMC, we performed Jagged1 stimulation of primary cultures. In populations that displayed significant growth, Jagged1 signaling through Notch2 suppressed proliferation; cultures with low growth potential were non-responsive to Jagged1. In addition, Jagged1 did not promote contractile smooth muscle actin nor have a significant effect on the mature differentiated phenotype. Thus, SMC derived from atherosclerotic lesions show distinct proteomic profiles, and have altered Notch signaling in response to Jagged1 as a differentiation stimulus, compared to normal SMC. 2018-05-23 2019-03 /pmc/articles/PMC6309523/ /pubmed/29795127 http://dx.doi.org/10.1038/s41374-018-0072-1 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Davis-Knowlton, Jessica
Turner, Jacqueline E.
Turner, Anna
Damian-Loring, Sydney
Hagler, Nicholas
Henderson, Terry
Emery, Ivette F.
Bond, Kyle
Duarte, Christine W.
Vary, Calvin P. H.
Eldrup-Jorgensen, Jens
Liaw, Lucy
Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling
title Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling
title_full Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling
title_fullStr Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling
title_full_unstemmed Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling
title_short Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling
title_sort characterization of smooth muscle cells from human atherosclerotic lesions and their responses to notch signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309523/
https://www.ncbi.nlm.nih.gov/pubmed/29795127
http://dx.doi.org/10.1038/s41374-018-0072-1
work_keys_str_mv AT davisknowltonjessica characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT turnerjacquelinee characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT turneranna characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT damianloringsydney characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT haglernicholas characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT hendersonterry characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT emeryivettef characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT bondkyle characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT duartechristinew characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT varycalvinph characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT eldrupjorgensenjens characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling
AT liawlucy characterizationofsmoothmusclecellsfromhumanatheroscleroticlesionsandtheirresponsestonotchsignaling